{"meshTagsMajor":["Mutation"],"meshTags":["Aged","Aged, 80 and over","Cell Line, Tumor","Cell Membrane","Disease Progression","Female","Genes, ras","Humans","Male","Middle Aged","Mutation","Pancreatic Neoplasms","Phosphatidylinositol 3-Kinases","Protein Structure, Tertiary","Proto-Oncogene Proteins c-akt"],"meshMinor":["Aged","Aged, 80 and over","Cell Line, Tumor","Cell Membrane","Disease Progression","Female","Genes, ras","Humans","Male","Middle Aged","Pancreatic Neoplasms","Phosphatidylinositol 3-Kinases","Protein Structure, Tertiary","Proto-Oncogene Proteins c-akt"],"genes":["AKT1","E17K","pleckstrin homology domain","AKT1","K-Ras"],"publicationTypes":["Journal Article","Research Support, Non-U.S. Gov\u0027t"],"abstract":"The prevalence of a novel somatic mutation (E17K) in the pleckstrin homology domain of AKT1 was investigated in pancreatic cancer using a quantitative pyrosequencing assay. This mutation was un-detectable in pancreatic cancer tissue samples (n\u003d65) and pancreatic cell line (n\u003d10) DNA suggesting that pancreatic cancer progression is mainly dependent on the K-Ras mutation.","title":"AKT1 (E17K) mutation in pancreatic cancer.","pubmedId":"18783292"}